Andrew Kim in Concord, New Hampshire

Medical School: University Of Massachusetts Medical School
Graduation Year: 2013
The Primary Medical Specialty for Andrew Kim is listed as: Dermatology
Approximate Years of Experience: 11
PAC (PECOS ID)#: 7719206226
NPI #: 1235572207
NPI Created On: 04/09/2013
NPI Last Updated Listed as: 05/29/2019
Primary Taxonomy Code: 207N00000X
License Number:
18120
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Celtic Insurance Company
• Humana
• Harvard Pilgrim Health Care Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Tangential biopsy of single skin lesion
2. Tangential biopsy of additional skin lesion
3. Punch biopsy of single skin lesion
4. Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs
5. Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
6. Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
7. Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs
8. Injection of up to 7 skin growths
9. Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
10. Repair of wound (7.6 to 12.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
11. Destruction of skin growth
12. Destruction of 2-14 skin growths
13. Destruction of 15 or more skin growths
14. Destruction of up to 14 skin growths
15. Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
16. Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
17. Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals
18. Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
19. Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
20. Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session